BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 31562957)

  • 1. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repurposing: Iron in the fire for older drugs.
    Sonaye HV; Sheikh RY; Doifode CA
    Biomed Pharmacother; 2021 Sep; 141():111638. PubMed ID: 34153846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repurposing a compelling cancer strategy with bottomless opportunities: Recent advancements in computational methods and molecular mechanisms.
    Dash R; Yadav M; Biswal J; Samanta S; Sharma T; Mohapatra S
    Indian J Pharmacol; 2023; 55(5):322-331. PubMed ID: 37929411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
    Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
    Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
    Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming cancer therapeutic bottleneck by drug repurposing.
    Zhang Z; Zhou L; Xie N; Nice EC; Zhang T; Cui Y; Huang C
    Signal Transduct Target Ther; 2020 Jul; 5(1):113. PubMed ID: 32616710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug rechanneling: A novel paradigm for cancer treatment.
    Kaushik I; Ramachandran S; Prasad S; Srivastava SK
    Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy.
    Rauf A; Joshi PB; Olatunde A; Hafeez N; Ahmad Z; Hemeg HA; Aljohani ASM; Al Abdulmonem W; Thiruvengadam M; Viswanathan D; Rajakumar G; Thiruvengadam R
    Med Oncol; 2024 Apr; 41(5):122. PubMed ID: 38652344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Drug Discovery By Structure-Based Repositioning Approach.
    Modh DH; Kulkarni VM
    Mini Rev Med Chem; 2024; 24(1):60-91. PubMed ID: 37165589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
    Palve V; Liao Y; Remsing Rix LL; Rix U
    Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing old drugs to fight multidrug resistant cancers.
    Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
    Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence, machine learning, and drug repurposing in cancer.
    Tanoli Z; Vähä-Koskela M; Aittokallio T
    Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
    [No Abstract]   [Full Text] [Related]  

  • 14. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
    Islam S; Wang S; Bowden N; Martin J; Head R
    Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
    Thilakasiri PS; Dmello RS; Nero TL; Parker MW; Ernst M; Chand AL
    Semin Cancer Biol; 2021 Jan; 68():31-46. PubMed ID: 31711994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
    K W To K; Cho WCS
    Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing drugs in oncology: From candidate selection to clinical adoption.
    Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
    Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing for cancer therapy, easier said than done.
    Gonzalez-Fierro A; Dueñas-González A
    Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing-an emerging strategy in cancer therapeutics.
    Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing for breast cancer therapy: Old weapon for new battle.
    Aggarwal S; Verma SS; Aggarwal S; Gupta SC
    Semin Cancer Biol; 2021 Jan; 68():8-20. PubMed ID: 31550502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.